The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer
Official Title: A Real-world Observational Study to Evaluate Lymph Metastases and Prognoses of the Chinese Patients With Thoracic T1-T3 Esophageal Cancer
Study ID: NCT03415815
Brief Summary: The real-world observational study was designed to explore lymph metastases and prognoses of the Chinese patients with thoracic T1-T3 esophageal cancer
Detailed Description: This trial is a real-world non-interventional observational study. The Chinese patients with thoracic T1-T3 esophageal cancer enrolled from Jan.1999 to Jun.2017 were included and the study data on pathologically diagnosed patient demographic/tumor biological characteristics were collected to evaluate the relevance of lymph metastases and prognoses of the subjects.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
China-Japan Friendship Hospital, Beijing, Beijing, China
China PLA General Hospital, Beijing, Beijing, China
Henan cancer hospital, Zhengzhou, Henan, China
Tongji Hospital Affiliated to Huazhong Technology Hospital, Wuhan, Hubei, China
Jiangsu cancer hospital, Nanjing, Jiangsu, China
Xi'an Tangdu Hospital, Xi'an, Shaanxi, China
Shanghai Chest Hospital, Shanghai, Shanghai, China
Huaxi Hospital Affiliated to Sichuan University, Chendu, Sichuan, China
Tianjin Chest Hospital, Tianjin, Tianjin, China
First Hospital Affiliated to Zhejiang University, Hangzhou, Zhejiang, China
Name: Yin Li
Affiliation: Henan Cancer Hospital
Role: PRINCIPAL_INVESTIGATOR